Linked Life Data

1281667

Source:http://linkedlifedata.com/resource/pubmed/id/1281667

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1993-1-26
pubmed:abstractText
Our unit has not investigated quality of life measurements specifically, and therefore I would like to make some general comments on the presentations by Professor Selby and Dr. Lindley. There are a number of influencing factors which affect the quality of life of cancer patients. An effective anti-emetic reduces nausea and vomiting and this could have an impact on patient well-being during the period of cytotoxic treatment. The question is, 'Do new, more effective anti-emetics improve the overall quality of life of cancer patients?' In order to show this we need to define very carefully the patient population under consideration.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0306-9443
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S24-5
pubmed:dateRevised
2009-9-15
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Quality of life measurements in anti-emetic trials: a discussion of Professor Selby's paper.
pubmed:affiliation
Division of Haematology/Oncology, Medizinische Hochschule, Hannover, Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Comment